TY - JOUR
T1 - Developmental outcomes at preschool age after fetal exposure to valproic acid and lamotrigine
T2 - Cognitive, motor, sensory and behavioral function
AU - Rihtman, Tanya
AU - Parush, Shula
AU - Ornoy, Asher
N1 - Funding Information:
Funding for this project was supported in part by the Martin and Vivian Levin Center for the Normal and Psychopathological Development of the Child and Adolescent, the Israel Association for Child Development and Rehabilitation and the Rama Shoval-Etial Fund. The authors offer special thanks to Dr. Svetlana Shechtman, Dr. Orna Diav-Citrin, Anna Zhivotovsky and Shani Ornoy, as well as to the parents and children who participated in the study.
PY - 2013/11
Y1 - 2013/11
N2 - This prospective, observational study assessed the development of preschool children aged 3-6 years, 11 months (. n=. 124) after in-utero anti-epileptic drug (AED) monotherapy exposure to valproic acid (VPA) (. n=. 30, mean age 52.00[±15.22] months) and lamotrigine (LT) (. n=. 42, mean age 50.12[±12.77] months), compared to non-exposed control children (. n=. 52, mean age 59.96[±14.51] months). As a combined group, AED-exposed children showed reduced non-verbal IQ scores, and lower scores on motor measures, sensory measures, and parent-report executive function, behavioral and attentional measures. When the VPA- and LT-exposed groups were analyzed separately, no cognitive differences were found, but control-VPA and control-LT differences emerged for most motor and sensory measures as well as control-VPA parent-report behavioral and attentional differences. No differences were noted between the VPA and LT groups. These findings suggest that VPA- and LT-exposed children should be monitored on a wider range of developmental measures than currently used, and at differing developmental stages.
AB - This prospective, observational study assessed the development of preschool children aged 3-6 years, 11 months (. n=. 124) after in-utero anti-epileptic drug (AED) monotherapy exposure to valproic acid (VPA) (. n=. 30, mean age 52.00[±15.22] months) and lamotrigine (LT) (. n=. 42, mean age 50.12[±12.77] months), compared to non-exposed control children (. n=. 52, mean age 59.96[±14.51] months). As a combined group, AED-exposed children showed reduced non-verbal IQ scores, and lower scores on motor measures, sensory measures, and parent-report executive function, behavioral and attentional measures. When the VPA- and LT-exposed groups were analyzed separately, no cognitive differences were found, but control-VPA and control-LT differences emerged for most motor and sensory measures as well as control-VPA parent-report behavioral and attentional differences. No differences were noted between the VPA and LT groups. These findings suggest that VPA- and LT-exposed children should be monitored on a wider range of developmental measures than currently used, and at differing developmental stages.
KW - Developmental outcomes
KW - Intra-uterine AED exposure
KW - Lamotrigine
KW - Monotherapy
KW - Valproic acid
UR - http://www.scopus.com/inward/record.url?scp=84882613559&partnerID=8YFLogxK
U2 - 10.1016/j.reprotox.2013.06.001
DO - 10.1016/j.reprotox.2013.06.001
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 23791930
AN - SCOPUS:84882613559
SN - 0890-6238
VL - 41
SP - 115
EP - 125
JO - Reproductive Toxicology
JF - Reproductive Toxicology
ER -